{"title":"Chinese guidelines for integrated diagnosis and treatment of intestinal microecology technologies in tumor application (2024 Edition).","authors":"Qiang Wang, Mingxin He, Jing Liang, Xiaohua Tan, Qingming Wu, Jun Wang, Xiaoan Li, Mingqiang Qiao, Ziming Huang, Qi Xie, Zhe Liu, Hua Ren, Liang Wang, Hao Zhou, Liang Shao, Rong Shu, Wei Wu, Wenyan Yang, Hua Wang, Zhiqiang Sun, Xiaojun Xu, Xingding Zhang, Zhiming Li, Yu Zhang, Jingye Meng, Yanli Zhu, Feng Chen, Rong Qu, Peng Chen, Shuluan Li, Yuanyuan Shi, Xin Mao, Bichuan Hu, Yukui Zhang, Yu J Cao, Zhi Guo","doi":"10.4103/jcrt.jcrt_32_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Intestinal microecology (IM) is the largest and most important microecological system of the human body. Furthermore, it is the key factor for activating and maintaining the physiological functions of the intestine. Numerous studies have investigated the effects of the gut microbiota on the different tissues and organs of the human body as well as their association with various diseases, and the findings are gradually being translated into clinical practice. The gut microbiota affects the occurrence, progression, treatment response, and toxic side effects of tumors. The deepening of research related to IM and tumors has opened a new chapter in IM research driven by methods and technologies such as second-generation sequencing and bioinformatics. The IM maintains the function of the host immune system and plays a pivotal role in tumor-control drug therapy. Increasing evidence has proven that the efficacy of tumor-control drugs largely depends on the IM balance, and strategies based on the IM technology show promising application prospects in the diagnosis and treatment of tumor. The Tumor and Microecology Professional Committee of the Chinese Anti-cancer Association gathered relevant experts to discuss and propose the \"Chinese guidelines for integrated diagnosis and treatment of IM technologies in tumor application (2024 Edition),\" which was established based on the research progress of the application of the IM technology in tumor to provide a basis for the standardization of the diagnosis and treatment of the IM technology in the tumor.</p>","PeriodicalId":94070,"journal":{"name":"Journal of cancer research and therapeutics","volume":"20 4","pages":"1130-1140"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer research and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jcrt.jcrt_32_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract: Intestinal microecology (IM) is the largest and most important microecological system of the human body. Furthermore, it is the key factor for activating and maintaining the physiological functions of the intestine. Numerous studies have investigated the effects of the gut microbiota on the different tissues and organs of the human body as well as their association with various diseases, and the findings are gradually being translated into clinical practice. The gut microbiota affects the occurrence, progression, treatment response, and toxic side effects of tumors. The deepening of research related to IM and tumors has opened a new chapter in IM research driven by methods and technologies such as second-generation sequencing and bioinformatics. The IM maintains the function of the host immune system and plays a pivotal role in tumor-control drug therapy. Increasing evidence has proven that the efficacy of tumor-control drugs largely depends on the IM balance, and strategies based on the IM technology show promising application prospects in the diagnosis and treatment of tumor. The Tumor and Microecology Professional Committee of the Chinese Anti-cancer Association gathered relevant experts to discuss and propose the "Chinese guidelines for integrated diagnosis and treatment of IM technologies in tumor application (2024 Edition)," which was established based on the research progress of the application of the IM technology in tumor to provide a basis for the standardization of the diagnosis and treatment of the IM technology in the tumor.
摘要:肠道微生态(IM)是人体最大、最重要的微生态系统。此外,它还是激活和维持肠道生理功能的关键因素。大量研究调查了肠道微生物群对人体不同组织和器官的影响,以及它们与各种疾病的关联,研究结果正逐步转化为临床实践。肠道微生物群影响肿瘤的发生、发展、治疗反应和毒副作用。在二代测序和生物信息学等方法和技术的推动下,肠道微生物群与肿瘤的相关研究不断深化,开启了肠道微生物群研究的新篇章。IM维持着宿主免疫系统的功能,在肿瘤控制药物治疗中起着举足轻重的作用。越来越多的证据证明,肿瘤控制药物的疗效在很大程度上取决于 IM 的平衡,基于 IM 技术的策略在肿瘤诊断和治疗中展现出广阔的应用前景。中国抗癌协会肿瘤与微生态专业委员会召集相关专家讨论提出了《中国肿瘤应用IM技术综合诊疗指南(2024年版)》,该指南是根据IM技术在肿瘤中应用的研究进展制定的,为规范IM技术在肿瘤中的诊疗提供依据。